Testing effectiveness (Phase 2)Study completedNCT05962606
What this trial is testing
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Who this might be right for
Community-acquired Pneumonia
Aptarion Biotech AG 150
Showing 14 of 0 results